BU-NOT-SET

CONTACT US
Unlocking the potential of RNA therapeutics through innovation and collaboration
  • Biologics
RNA
Insight
Using in vitro release testing (IVRT) to analyse semi-solid topical formulations
  • Analytical chemistry
Cream squeezed out of a tube
White paper
Enhancing the production of RNA with continuous manufacturing
  • Biologics
Continuous manufacturing of RNA
Insight
GERTEIS MINI-PACTOR® Advanced dry granulation services
  • Drug product
GERTEIS MINI-PACTOR®
Fact sheet
Overcoming oncolytic virus therapy production challenges through collaboration
  • Biologics
Oncolytic virus therapy production
Case study
Emerging trends set to impact drug development in 2024
  • Industry trends
Trends in drug development
Insight
Webinar: ATMPs in focus: Essential CMC strategies for every phase
  • Biologics
ATMPs in focus
Webinar
Trends set to make an impact on oral solid dose development in 2024
  • Drug product
  • Industry trends
Oral solid dose
Insight
Enhancing AAV therapy development and manufacture with a platform approach
  • Biologics
Enhancing AAV therapy
Insight
Insight
  • Drug product
  • Industry trends
2023: fill and finish demand expected to continue as the industry faces new challenges
Insight
  • Drug product
  • Industry trends
What does 2023 hold for oral solid dosage forms?
Insight
  • Sustainability
Is it time to introduce science based targets for climate change?
Insight
  • Drug product
  • Industry trends
Addressing the key pitfalls hindering technology transfer success
Case study
  • Analytical chemistry
  • Drug product
Overcoming tablet dissolution challenges with formulation expertise
Insight
  • Industry trends
  • Manufacturing
Today’s potent oral dose forms require flexible manufacturing environments
Insight
  • Analytical chemistry
  • Drug product
Benefits of reformulation strategies
Case study
  • Drug product
  • Manufacturing
Supporting first lyophilised mRNA vaccine to pivotal trial
Fact sheet
  • Drug product
  • Manufacturing
LAB+ blow-fill-seal system